FDA NDC Directory · JSON-LD · Markdown

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate

NDC 72516-014 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerOryza Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA210293
Dosage form / routeTABLET · ORAL
Active ingredientsAMPHETAMINE ASPARTATE MONOHYDRATE (2.5 mg/1)
AMPHETAMINE SULFATE (2.5 mg/1)
DEXTROAMPHETAMINE SACCHARATE (2.5 mg/1)
DEXTROAMPHETAMINE SULFATE (2.5 mg/1)
Marketing started20201019
Package count1

External sources

Source: openFDA. Public-domain (CC0).